Quinoxalin-2(1H)-one derived AMPA-receptor antagonists: Design, synthesis, molecular docking and anticonvulsant activity
- 137 Downloads
A new series of 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-ones (3–14) were designed and synthesized in order to evaluate their α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-receptor antagonism as a proposed mode of their anticonvulsant activity. The structure of the synthesized compounds was confirmed by elemental analysis and spectral data (infrared, 1H nuclear magnetic resonance (NMR), 13CNMR, and mass). The molecular design was performed for all synthesized compounds to predict their binding affinity towards AMPA-receptor in order to rationalize their anticonvulsant activity in a qualitative way and explain the possible interactions that might take place between the tested derivatives and AMPA receptor in comparing to compounds III and YM872 in order to obtain the anticonvulsant effect. The data obtained from the molecular modeling was strongly correlated with that obtained from the biological screening which revealed that; compounds 14 b , 14 a , and 13 b showed the highest binding affinities toward AMPA-receptor and also showed the highest anticonvulsant activities against pentylenetetrazole-induced seizures in experimental mice. The relative potencies of these compounds were 1.89, 1.83, and 1.51 respectively, in comparing to diazepam.
KeywordsQuinoxaline Molecular docking AMPA antagonists Anticonvulsant agents
The authors extend their appreciation and thanking to Prof. Dr. Ahmed M. Mansour, Pharmacology & Toxicology Department, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt for helping in the pharmacological screening.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no competing interests.
- Bonuga YR, Nathb AR, Balram B, Ram B (2013) Synthesis and antibacterial activity of 3,4-dihydroquinoxalin-2(1H)-one derivatives. Der PharmaChemica 5(5):296–300Google Scholar
- El-Adl K (2011) Design and synthesis of some novel 2-(5-methylbenzoxazol-2-ylsalfanyl)-N-(4-substitutedphenyl)-acetamide derivatives with potential anticonvulsant activity. Az J Pharm Sci 44:183–204Google Scholar
- El-Helby AA, Ayyad RRA, El-Adl K, Helmy S, Abdel-Rahman AA, Eissa IH, Elwan A (2016) Design, molecular docking and synthesis of some novel 4-acetyl-1-substituted-3,4-dihydroquinoxalin-2(1H)-one derivatives foranticonvulsant evaluation as AMPA-receptor antagonists. Med Chem Res 25(12):3030–3046CrossRefGoogle Scholar
- El-Helby AA, Ibrahim MK, Abdel-Rahman AA, Ayyad RRA, Menshawy MA, El-Adl K (2009) Synthesis, molecular modeling and anticonvulsant activity of benzoxazole derivatives. Az J Pharm Sci 40:252–270Google Scholar
- Elkaeed E, Ghiaty A, El-Morsy A, El-Gamal K, Sak H (2014) Synthesis and biological evaluation of some quinoxaline-2-one derivatives as novel anticonvulsant agents. Chem Sci Rev Lett 3(12):1375–1387Google Scholar
- Ibrahim M-K, Abd-Elrahman AA, Ayyad RRA, El-Adl K, Mansour AM, Eissa IH (2013) Design and synthesis of some novel 2-(3-methyl-2-oxoquinoxalin-1(2H)-yl)-N-(4-(substituted)phenyl)-acetamide derivatives for biological evaluation as anticonvulsant agents. Bull Fac Pharm Cairo Univ 51:101–111CrossRefGoogle Scholar
- Loscher W, Rogawski MA (2002) Epilepsy. In: Lodge D, Danysz W, Parsons CG (eds) Ionotropic glutamate receptors as therapeutic targets. F.P. Graham Publishing Co., Johnson City, TN, p 91–132Google Scholar